The landscape of blood sugar treatment is changing with the emergence of GLP-1 patches . These innovative devices offer a likely simpler alternative to injections for individuals living with type 2 diabetes . Such a system deliver a GLP-1 agonist directly through the dermis , circumventing the necessity for daily injections and possibly enhancing c